Tirzepatide Weight Loss in Miami, FL
Experience the most effective FDA-approved weight loss medication available. Tirzepatide — the dual-action GLP-1/GIP receptor agonist behind Mounjaro and Zepbound — targets two appetite-regulating hormones for superior results, guided by our clinical team at Femme Aesthetics.
5.0 on Google108 reviewsSouth Miami
- Procedure
- Weekly Injection
- Results Visible
- 4 – 8 Weeks
- Program
- Ongoing
- Downtime
- None
What Is Tirzepatide?
Tirzepatide is an FDA-approved dual-action injectable medication that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is the active ingredient in Mounjaro (approved for type 2 diabetes) and Zepbound (approved specifically for chronic weight management).
Unlike single-action GLP-1 medications such as semaglutide, tirzepatide activates two incretin hormone pathways simultaneously. This dual mechanism provides a more comprehensive approach to appetite regulation, blood sugar control, and fat metabolism — which is why clinical trials have shown tirzepatide produces greater weight loss than any other approved medication in its class.
At Femme Aesthetics, our medical providers prescribe and supervise tirzepatide as part of a medically managed weight loss program. From your initial health evaluation and lab work through dosage adjustments and ongoing monitoring, we guide every step of your journey toward sustainable weight loss.
Why Choose Tirzepatide
Benefits of Tirzepatide
- 01Up to 22.5% Body Weight LossIn the SURMOUNT clinical trials, patients on the highest dose of tirzepatide lost an average of 22.5% of their body weight — significantly more than any other approved GLP-1 medication, including semaglutide.
- 02Dual Hormone TargetingTirzepatide is the only FDA-approved weight loss medication that activates both GLP-1 and GIP receptors, providing two complementary pathways for appetite suppression, blood sugar regulation, and metabolic improvement.
- 03Superior Appetite RegulationBy mimicking two satiety hormones, tirzepatide reduces hunger and cravings more effectively, making it easier to maintain a caloric deficit and develop healthier eating patterns naturally.
- 04Blood Sugar ImprovementTirzepatide significantly improves blood sugar control and insulin sensitivity, making it especially beneficial for patients with type 2 diabetes or pre-diabetic conditions alongside their weight management goals.
- 05Cardiovascular BenefitsClinical data suggests tirzepatide may reduce cardiovascular risk factors including blood pressure, triglycerides, and waist circumference, contributing to improved overall cardiometabolic health.
- 06Simple Weekly InjectionOne self-administered subcutaneous injection per week is all it takes. We teach you how during your first visit so you can manage it comfortably at home on the same day each week.
Dual-Action Mechanism
How Tirzepatide Works
Tirzepatide stands apart from other weight loss medications because it activates two hormone pathways that work together to regulate appetite, metabolism, and blood sugar.
GLP-1 Receptor Activation
Like semaglutide, tirzepatide activates GLP-1 receptors that slow gastric emptying, reduce appetite, and stimulate insulin release. This pathway helps you feel full longer and reduces food cravings after meals.
GIP Receptor Activation
Tirzepatide also activates GIP receptors — a second incretin hormone pathway that enhances insulin sensitivity, promotes fat metabolism, and further reduces appetite. This is what makes tirzepatide unique among weight loss medications.
Appetite & Craving Reduction
The combined effect of GLP-1 and GIP activation produces more powerful appetite suppression than either pathway alone, helping patients reduce caloric intake naturally without constant hunger or willpower battles.
Metabolic Improvement
Beyond weight loss, tirzepatide improves multiple metabolic markers including fasting blood glucose, HbA1c, insulin resistance, triglycerides, and blood pressure — supporting whole-body metabolic health.
Tirzepatide vs. Semaglutide
Head-to-head trials show tirzepatide produces greater weight loss than semaglutide. Patients on tirzepatide lost up to 22.5% of body weight compared to approximately 15% with semaglutide, making it the most effective option currently available.
Your Visit
What to Expect
-
Before Treatment
Consultation & Evaluation
Your tirzepatide journey begins with a comprehensive initial consultation. Our clinical team will determine if you are a candidate based on your health profile, BMI, and weight loss goals.
- Complete health assessment and review of medical history
- Lab work and blood panel to evaluate metabolic health
- BMI evaluation and body composition analysis
- Discussion of tirzepatide vs. semaglutide and which is right for you
- Review of current medications and potential interactions
-
During Treatment
Dose Escalation Protocol
Tirzepatide follows a structured dose escalation schedule to minimize side effects and optimize results. You start at 2.5 mg weekly for the first four weeks, then gradually increase through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum of 15 mg based on your response and tolerance. During your first visit, we teach you how to self-administer the injection at home comfortably and safely.
-
After Treatment
Ongoing Monitoring & Results
Regular follow-up appointments ensure your progress is on track and allow our medical providers to fine-tune your care. Most patients begin seeing meaningful weight loss within 4 to 8 weeks.
- Regular weigh-ins and progress assessments
- Dosage adjustments based on response and tolerance
- Side effect monitoring and management
- Lifestyle and nutritional guidance to complement medication
- Program continues as long as medically appropriate with ongoing clinical support
Possible Side Effects
The most common side effects of tirzepatide include nausea (especially during dose escalation), diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain. These gastrointestinal symptoms are typically mild to moderate and tend to diminish as the body adjusts to each new dose level.
Serious but rare side effects include pancreatitis, gallbladder problems, allergic reactions, and low blood sugar (particularly when combined with other diabetes medications). Tirzepatide carries a boxed warning about the risk of thyroid C-cell tumors observed in animal studies, though this has not been confirmed in humans. Our clinical team monitors you closely throughout the program, adjusts dosing to minimize discomfort, and ensures your safety at every stage.
Transparent Pricing
What this costs
Tirzepatide is priced by the volume dispensed, which tracks the dose you titrate up to. Every patient starts with a consultation — your first one is complimentary — and treatment is only dispensed after it.
- Tirzepatide 2ml–8ml$500–$1,365
Prices vary with how much product a treatment plan calls for and which areas are treated. See the full menu on our pricing page, or book a consultation and we will quote you before anything begins.
See every priceWhat is tirzepatide?
Tirzepatide is an FDA-approved dual-action GLP-1 and GIP receptor agonist medication used for weight management and type 2 diabetes. It is the active ingredient in both Mounjaro (approved for diabetes) and Zepbound (approved specifically for chronic weight management). By targeting two incretin hormones instead of one, tirzepatide offers a unique mechanism that can produce greater weight loss than single-action GLP-1 medications like semaglutide.
How is tirzepatide different from semaglutide?
The key difference is that tirzepatide targets two hormones — GLP-1 and GIP — while semaglutide targets only GLP-1. This dual-action mechanism allows tirzepatide to regulate appetite and blood sugar through two complementary pathways. In head-to-head clinical trials (SURPASS studies), tirzepatide produced greater weight loss than semaglutide, with patients losing up to 22.5% of their body weight compared to approximately 15% with semaglutide.
How much weight can I lose with tirzepatide?
In the SURMOUNT clinical trials, patients taking the highest dose of tirzepatide (15 mg) lost an average of 22.5% of their body weight over 72 weeks. Individual results vary based on starting weight, dosage, adherence, diet, and activity level. Our medical providers will set realistic goals during your consultation based on your personal health profile.
What are the side effects of tirzepatide?
The most common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain. These are typically mild and tend to diminish as your body adjusts to the medication, especially during the dose escalation phase. Serious but rare side effects include pancreatitis, gallbladder problems, and allergic reactions. Our clinical team monitors you closely throughout the program to manage any symptoms.
How often do I take tirzepatide?
Tirzepatide is administered as a once-weekly subcutaneous injection. You can inject it on any day of the week, but it should be the same day each week. During your first visit, our team will teach you how to self-administer the injection comfortably at home.
Am I a candidate for tirzepatide?
Tirzepatide may be appropriate for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. Our medical providers will conduct a full health evaluation, including lab work, to determine if tirzepatide is the right option for you during your initial consultation.
Ready to Start Tirzepatide?
Schedule a personalized tirzepatide consultation at Femme Aesthetics. Our medical providers will evaluate your health, discuss whether tirzepatide or semaglutide is right for you, and create a program tailored to your goals.
In English or Spanish, whichever you’d rather.
Explore More
Related Services
Semaglutide
FDA-approved GLP-1 receptor agonist for medical weight loss, the active ingredient in Ozempic and Wegovy.
Medical Weight Loss
Comprehensive, provider-supervised weight management with FDA-approved GLP-1 medications and personalized guidance.
Hormone Therapy
Restore hormonal balance to support metabolism, energy, and overall well-being.
Sources
- U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management.
- U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022 (SURMOUNT-1).